Peptide‐based ligand antagonists block a Vibrio cholerae adhesin
FEBS Letters · 2026
DOI: 10.1002/1873-3468.70231 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, 2026. Verfasst von Mingyu Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, McGill University, Montreal, Canada. Hauptthemen laut MEDLINE: Vibrio cholerae, Adhesins, Bacterial, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Antimicrobial Resistance Network studentship, McGill Centre for Structural Biology Research Bluesky award, NSERC Undergraduate Student Research Award.
Abstract (Originalsprache)
Vibrio cholerae , the causative agent of cholera, uses surface proteins such as the repeats‐in‐toxin (RTX) adhesin FrhA to colonize hosts and initiate infection. Blocking bacterial adhesion represents a promising therapeutic strategy to treat infections without promoting drug resistance. FrhA contains a peptide‐binding domain (PBD) that is key for hemagglutination, human epithelial cell binding, and V. cholerae biofilm formation. Previous studies identified a lead pentapeptide ligand with the sequence Ala‐Gly‐Tyr‐Thr‐Asp (AGYTD) that blocks V. cholerae colonization of the mouse small intestine at high micromolar concentrations. In this study, a structure‐guided approach identified a minimal D‐amino acid‐containing tripeptide motif with higher affinity for the FrhA‐PBD and predicted metabolic stability. Our results contribute to the development of anti‐adhesion strategies to combat infections. Impact statement Our study elucidates the molecular basis of peptide recognition by the Vibrio cholerae adhesin FrhA and develops minimal D‐amino‐acid peptides that block adhesion with nanomolar affinity. These findings advance understanding of RTX adhesins and provide a structural blueprint for next‐generation anti‐adhesion therapeutics against cholera and related infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, McGill University, Montreal, Canada.
- Centre de recherche en biologie structurale, McGill University, Montreal, Canada.
- Department of Chemistry, Université de Montréal, Montreal, Canada.
- Department of Biological and Molecular Sciences, Queen's University, Kingston, Canada.
- Department of Molecular Microbiology and Immunology, University of Texas at San Antonio, San Antonio, Texas, USA.
ORCID-Profile: Peter Davies, Shuaiqi Guo
Förderung
- Canadian Antimicrobial Resistance Network studentship
- McGill Centre for Structural Biology Research Bluesky award
- NSERC Undergraduate Student Research Award
- McGill Faculty of Medicine and Health Sciences
- McGill Centre for Structural Biology Research Studentship
- CIHR
- Fonds de Recherche du Québec - Santé
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Wang, M., Du, G., Yongo-Luwawa, C., Lu, A., Kinrade, B., Munro, K., Klose, K. E., Lubell, W. D., Davies, P., & Guo, S. (2026). Peptide‐based ligand antagonists block a Vibrio cholerae adhesin. FEBS Letters. https://doi.org/10.1002/1873-3468.70231
Vancouver
Wang M, Du G, Yongo-Luwawa C, Lu A, Kinrade B, Munro K, et al. Peptide‐based ligand antagonists block a Vibrio cholerae adhesin. FEBS Letters. 2026. doi:10.1002/1873-3468.70231
BibTeX
@article{Wang2026,
author = {Wang, Mingyu and Du, Grace and Yongo-Luwawa, Charity and Lu, Angelina and Kinrade, Brett and Munro, Kim and Klose, Karl E and Lubell, William D and Davies, Peter and Guo, Shuaiqi},
title = {Peptide‐based ligand antagonists block a Vibrio cholerae adhesin},
journal = {FEBS Letters},
year = {2026},
doi = {10.1002/1873-3468.70231}
}
EUVIMED